RECRUITING

Psorcast Mobile Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

Official Title

Psorcast Study: A Smartphone-based Study of Psoriasis and Psoriatic Arthritis

Quick Facts

Study Start:2022-01-01
Study Completion:2027-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05621369

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult age 18 and older who consent to participate in the study
  2. * Own a compatible iPhone or iPod Touch device running iOS 12.2 or above
  3. * Be able to read and understand an official language of the country of participation
  1. * Age 17 years or younger
  2. * Not a resident of the a country where the app is approved for use
  3. * Not have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later)
  4. * Not be able to read and understand an official language of the country of participation

Contacts and Locations

Study Contact

Solveig K Sieberts, Ph.D
CONTACT
206-928-8266
psorcast@sagebase.org
Christine Suver, Ph.D
CONTACT
206-667-2128
christine.suver@sagebase.org

Principal Investigator

Solveig Sieberts, Ph.D
PRINCIPAL_INVESTIGATOR
Sage Bionetworks
Jose Scher, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Medical Center
Joseph Merola, MD, MMSc
PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital & Harvard Medical School

Study Locations (Sites)

Sage Bionetworks
Seattle, Washington, 98109
United States

Collaborators and Investigators

Sponsor: Sage Bionetworks

  • Solveig Sieberts, Ph.D, PRINCIPAL_INVESTIGATOR, Sage Bionetworks
  • Jose Scher, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Medical Center
  • Joseph Merola, MD, MMSc, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital & Harvard Medical School

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-01
Study Completion Date2027-01-31

Study Record Updates

Study Start Date2022-01-01
Study Completion Date2027-01-31

Terms related to this study

Keywords Provided by Researchers

  • Psoriasis
  • Psoriatic Arthritis
  • Psoriatic Disease
  • Health app research
  • mHealth research
  • Mobile health research

Additional Relevant MeSH Terms

  • Psoriatic Arthritis
  • Psoriasis
  • Psoriatic Conditions
  • Dermatologic Disease
  • Rheumatologic Disease
  • Psoriatic Nail
  • Plaque Psoriasis
  • Joint Pain
  • Dactylitis